Paricalcitol Injection, Solution
Product Images NDC 16729-310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paricalcitol (NDC 16729-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Paricalcitol Inj 10 Mcg Per 2 mL 25 Vial Carton
Paricalcitol Inj 10 Mcg Per 2 mL Label
This is a medication label for Roetazan, a type of paricalcitol that is intended for intravenous use through hemodialysis. The medication is available in a multi-dose vial with a strength of 5mg/mL. It should only be administered through the vascular access port. The label also includes the NDC number, which can be used for identification purposes.*
Paricalcitol Inj 2 Mcg Per mL 1 Vial Carton
Paricalcitol Inj 2 Mcg Per mL 25 Vial Carton
Paricalcitol Inj 2 Mcg Per mL Label
NDC 16729-310-63 is a single-dose vial of Paricalcitol injection for intravenous use through hemodialysis vascular access port only. The unused portion should be discarded. Rx Only. The product is manufactured for Accord Healthcare Inc., located in Durham, NC 27703, and made in INDIA. The text contains some garbled characters and is not readable in some places.*
Paricalcitol Inj 5 Mcg Per mL 1 Vial Carton
Paricalcitol Inj 5 Mcg Per mL 25 Vial Carton
Paricalcitol Inj 5 Mcg Per mL Label
Chemical Structure For Paricalcitol (Paricalcitol Inj Figure 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.